MR-guided biopsy using respiratory-triggered high-resolution T2-weighted sequences

Magnetic resonance-guided upper abdominal biopsies in a high-field wide-bore 3-T MRI system: feasibility, handling, and needle artefacts

OBJECTIVE

To investigate the feasibility and handling of abdominal MRI-guided biopsies in a 3-T MRI system.

METHODS

Over a 1-year period, 50 biopsies were obtained in 47 patients with tumours of the upper abdominal organs guided by 3-T MRI with a large-bore diameter of 70 cm. Lesions in liver (47), spleen (1) and kidney (2) were biopsied with a coaxial technique using a 16-G biopsy needle guided by a T1-weighted three-dimensional gradient recalled echo volumetric interpolated breath-hold examination (T1w-3D-GRE-VIBE) sequence. Sensitivity, specificity, accuracy, complication rate, interventional complexity, room/intervention time and needle artefacts were determined.

RESULTS

A sensitivity of 0.93, specificity of 1.0 and accuracy of 0.94 were observed. Three patients required a rebiopsy. There was a minor complications rate of 13.6%, and no major complications were observed. Histopathology revealed 38 malignant lesions, and 3-month follow-up confirmed 9 benign lesions. Mean lesion diameter was 3.4 ± 3.1 cm (50% being smaller than 2 cm). Mean needle tract length was 10.8 ± 3.3 cm. Median room time was 42.0 ± 19.8 min and intervention time 9.3 ± 8.1 min. Needle artefact size was about 9-fold greater for perpendicular access versus access parallel to the main magnetic field.

CONCLUSION

Biopsies of the upper abdomen can be performed with great technical success and easy handling because of the large-bore diameter. The MRI-guided biopsy needle had an acceptable susceptibility artefact at 3 T. However future research must aim to reduce the susceptibility effects of the biopsy systems.

MRI-guided abdominal biopsy in a 0.23-T open-configuration MRI system

The purpose of this study was to test the hypothesis that when ultrasound (US) guidance is not feasible, abdominal biopsies can be performed safely and accurately under magnetic resonance imaging (MRI) guidance in a low-field environment. MRI-guided abdominal biopsy was performed on 31 consecutive patients, in whom US-guided abdominal biopsy was not possible because the lesion was not visualized in US (n=27) or an US-guided procedure was not considered safe (n=4). The locations of the lesions were liver (n=14), pancreas (n=6), lymph node (n=4), retroperitoneal mass (n=3), adrenal gland (n=3) and spleen (n=1). The average size of the lesion was 2.2 cm (range 1-4 cm) in maximum diameter. All procedures were done by using a 0.23-T open-configuration C-arm-shaped MRI scanner with interventional optical tracking equipment and software. Fine-needle aspiration (FNA) biopsy was performed on all 31 patients; 18 patients underwent both FNA biopsy and cutting needle core biopsy. Procedures were evaluated for diagnostic sensitivity, specificity and accuracy as well as procedure time and complications. The FNA biopsy specimens were adequate for interpretation in 27 (87%) of 31 cases. Two of these proved to be false-negative findings during follow-up or subsequent biopsy. The final diagnosis was malignant in 15 and benign in 16 patients. The sensitivity, specificity and accuracy of FNA biopsy were 71, 100 and 81%, respectively. Of the 18 core-needle biopsies, one was determined false-negative owing to nonrepresentativeness. The sensitivity, specificity and accuracy of histological samples were 90, 100 and 94%, respectively. The needle time was 19 min on average and the mean room time was 1 h 48 min. No immediate or late complications occurred. MRI-guided abdominal biopsy can be performed safely and accurately in a low-field environment in patients for whom an US-guided procedure is not feasible.

MR-guided core biopsies using a closed 1.0 T imager. First clinical results

OBJECTIVE

High soft-tissue contrast and multiplanar imaging capabilities of MRI may be advantageous in biopsy guidance compared to CT. We report our first results with MR-guided core biopsies using a closed 1.0 T MR imager.

METHODS AND PATIENTS

In ten patients, seven liver lesions and one lesion each in the muscle of the back, the gluteal muscle and in the breast were biopsied under MR guidance using MR-compatible needles (Tru-Cut type, 18G and 14G). For control scans T1-weighted turbo-spin-echo (TSE), gradient-echo and T2-weighted TSE sequences were used.

RESULTS

In all patients, the suspicious lesions and the biopsy needle were exactly delineated in MR control scans. In nine out of ten patients, the suspicious lesion was clarified histologically. Controls of needle position in a second plane were performed twice. Pushing the inner stylet alone resulted in a distortion of the needle in several cases in its flat area. The small diameter of the MR gantry was inconvenient for a few patients. One complication (intrahepatic bleeding) was observed, which healed up without consequences.

CONCLUSION

Using a closed 1.0 T MR imager MR-guided core biopsies can be conducted efficiently. Core biopsies should be taken by pulling and pushing the outer cannula. Advantageous compared to CT are the multiplanar imaging capabilities, while the smaller gantry is disadvantageous.